Is Cairdac the future of pacemakers?
Cairdac, a French pacemaker startup, has recently published their first two patent applications. The company seeks to revolutionize the pacemaker industry by removing one major problem: replacement surgery when batteries die. Like many other modern pacemakers, Cairdac also uses a leadless design, which reduces some adverse effects. Its novelty, however, is the use of a piezoelectric energy harvester that gathers energy from the low frequency vibration of heart beats. The device will also learn to better characterize the presence of atrial events.

Related Posts
April 15, 2021
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Activity,AI Biotech / Diagnostics: Neurology
April 8, 2021
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
April 1, 2021
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Neurology


